AVEO PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aveo Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 3, 2022 was 34.8M shares, a 1.13% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 34.8M +389K +1.13% Nov 3, 2022 10-Q 2022-11-07
Q2 2022 34.6M +240K +0.7% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 34.5M +7.34M +27.1% Mar 9, 2022 10-K 2022-03-14
Q3 2021 34.4M +5.56M +19.3% Nov 1, 2021 10-Q 2021-11-08
Q2 2021 34.4M +8.57M +33.2% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 27.1M +11M +68.7% Mar 15, 2021 10-K 2021-03-16
Q3 2020 28.8M -132M -82.1% Nov 6, 2020 10-Q 2020-11-09
Q2 2020 25.8M -135M -83.9% Aug 7, 2020 10-Q 2020-08-10
Q1 2020 16.1M -123M -88.4% Mar 9, 2020 10-K 2020-03-16
Q3 2019 161M +35.4M +28.2% Nov 4, 2019 10-Q 2019-11-12
Q2 2019 161M +41.7M +35% Aug 2, 2019 10-Q 2019-08-08
Q1 2019 139M +20.1M +16.9% Mar 8, 2019 10-K 2019-03-14
Q3 2018 125M +7.03M +5.94% Nov 8, 2018 10-Q 2018-11-09
Q2 2018 119M +722K +0.61% Aug 3, 2018 10-Q 2018-08-07
Q1 2018 119M +43M +56.7% Mar 8, 2018 10-K 2018-03-13
Q3 2017 118M +42.5M +56% Nov 3, 2017 10-Q 2017-11-07
Q2 2017 118M +42.4M +56% Aug 8, 2017 10-Q 2017-08-09
Q1 2017 75.9M +17.7M +30.4% Mar 17, 2017 10-K 2017-03-22
Q3 2016 75.9M +17.7M +30.4% Oct 28, 2016 10-Q 2016-11-04
Q2 2016 75.9M +20.1M +36.2% Jul 29, 2016 10-Q 2016-08-04
Q1 2016 58.2M +3.11M +5.65% Mar 9, 2016 10-K 2016-03-15
Q3 2015 58.2M +5.92M +11.3% Nov 2, 2015 10-Q 2015-11-09
Q2 2015 55.7M +3.42M +6.54% Aug 3, 2015 10-Q 2015-08-10
Q1 2015 55.1M +2.8M +5.37% May 1, 2015 10-Q 2015-05-07
Q3 2014 52.3M +393K +0.76% Nov 3, 2014 10-Q 2014-11-05
Q2 2014 52.3M +128K +0.25% Aug 1, 2014 10-Q 2014-08-11
Q1 2014 52.3M +381K +0.73% May 1, 2014 10-Q 2014-05-07
Q3 2013 51.9M +8.13M +18.6% Nov 1, 2013 10-Q 2013-11-07
Q2 2013 52.2M +8.5M +19.5% Aug 1, 2013 10-Q 2013-08-08
Q1 2013 51.9M +8.31M +19.1% May 1, 2013 10-Q 2013-05-10
Q3 2012 43.7M +529K +1.23% Nov 1, 2012 10-Q 2012-11-08
Q2 2012 43.7M +573K +1.33% Aug 1, 2012 10-Q 2012-08-07
Q1 2012 43.6M May 1, 2012 10-Q 2012-05-09
Q3 2011 43.2M Nov 1, 2011 10-Q 2011-11-08
Q2 2011 43.1M Aug 1, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.